You've got just a few days left to submit your proposal to join us as a new Group Leader
📅 Applications close 2nd November
Package includes:
🪙Multi-year funding
🧪Core Facility Access
🥼 #Postdoc & #PhD positions
🤝Mentorship
Visit our website to apply:
www.cruk.manchester.ac.uk/career/new-g...
Along with this example from @cruk-ci.bsky.social, we contributed to the recent @crukpolicy.bsky.social report on how UK immigration policy is negatively affecting international recruitment of cancer researchers
Read the full story in @theobserveruk.bsky.social here: observer.co.uk/news/nationa...
Online now! Cell-free DNA #methylome and #fragmentome analysis for relapse monitoring of #EwingSarcoma
By S. Richardson, M. McCabe, @florentmouliere.bsky.social & colleagues @cancerresearchuk.org @manchester.ac.uk
➡️ doi.org/10.1038/s44321-026-00396-7
I am excited to share our review in Nature Reviews Genetics. Liquid biopsy are becoming better, smaller, faster and smarter. This next generation of #liquidbiopsy, #cfDNA multi-modal assays is unlocking applications in MCED, MRD, toxicity, functional and biological analysis of cancers, and beyond.
@alexdickinson, not on Bluesky, on the concerns he has about the performance of the Grail Bio $GRAL MCED Galleri test
Almost 2️⃣ years in…
Our MANIFEST AGM convened scientists, clinicians, patient partners & industry. Keynotes from Prof Levesque & Prof Rattray + Prof Turajlić setting the course ahead.
Big thank you to all for continuing to believe in the vision; to tackle the hard questions in #CancerImmunotherapy.
Exciting conference alert!
sites.manchester.ac.uk/from-lab-to-...
Fantastic speakers including Chris Marine, Christian Blank
Melanoma evolution
Local microenvironment of melanoma
Melanoma-host interactions
Precision immunotherapy
Emerging therapeutics
Clinical trials and real-world data
Pleased to share results from the CAcTUS Phase II trial of ctDNA-guided therapy in BRAF-mutant advanced melanoma are now published! 🌵🧬
CAcTUS is the first melanoma trial to adapt treatment based on ctDNA testing.
Read: www.nature.com/articles/s41...
Do you know anyone keen to study cancers of unmet need and understand how to improve their responses to treatment? We are looking for a curious enthusiastic scientific officer to work at @cruknbc.bsky.social , close ties with @manchester.ac.uk and @christieinstitute.bsky.social
The Lee lab is expanding! We are really interested in mechanisms of local and systemic immune tolerance particularly in liver metastases - X2 research technicians
💡 Creative fun environment
🌱 Opportunities to grow
🫂 Highly collaborative with clinical+basic research
📢 Please spread word!